Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000154678 | SCV000204356 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | Thr400Thr in exon 8 of ABCC9: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue, is not located within the splice consensus sequence. It has been identified in 0.1% (3/3738) of Africa n American chromosomes from a broad population by the NHLBI Exome Sequencing Pro ject (http://evs.gs.washington.edu/EVS; dbSNP rs150096625). Thr400Thr in exon 8 of ABCC9 (rs150096625; allele frequency = 0.1%, 1/3738) ** |
Gene |
RCV001719957 | SCV000714322 | likely benign | not provided | 2020-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617899 | SCV000735712 | likely benign | Cardiovascular phenotype | 2016-12-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000862430 | SCV001002938 | likely benign | Dilated cardiomyopathy 1O | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000154678 | SCV001362415 | benign | not specified | 2019-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004544409 | SCV004769012 | likely benign | ABCC9-related disorder | 2019-11-18 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |